Back to results
US 2024/0182816 A1Published application
Treatment composition
AssigneeThe Procter & Gamble Company
InventorsMattia COLLU, Johan SMETS, Conny Erna Alice JOOS, Susana FERNANDEZ PRIETO, Maria Carolina ABREU MESTRE, Gaetano ALETTA, Linsheng FENG, Robert Stanley BOBNOCK
Life of this patent
Estimating the term…
Abstract
A treatment composition that includes a treatment adjunct and a population of core/shell delivery particles, where the shells of the particles are made, in part, from biopolymers, and where the particles are characterized as having certain ductile properties. Related methods of making and using such compositions.
Claims20
A treatment composition comprising:
- a treatment adjunct, and
- a population of delivery particles,
- wherein the delivery particles comprise a core and a shell surrounding the core,
- wherein the core comprises a benefit agent,
- wherein the shell comprises a polymeric material,
- wherein the polymeric material comprises the reaction product of a biopolymer and a cross-linking agent,
- wherein the population of delivery particles is characterized by at least one, preferably at least two, of the following:
- (a) a Volume-Weighted Ductile Energy greater than about 3.5, based on fifty delivery particles selected at random being compressed by a blunt probe moving at 2 μm/s;
- (b) at least about 30%, by number, of the delivery particles are characterized as Completely Ductile particles, based on fifty delivery particles selected at random being compressed by a blunt probe moving at 2 μm/s;
- (c) less than 35%, by number, of the delivery particles are characterized as Single Rupture particles, based on fifty delivery particles selected at random being compressed by a blunt probe moving at 2 μm/s.
7 more elements
Dependencies are inferred from the claim text.